- Home
- MWH vs PTGX Comparison
MWH vs PTGX Comparison
Compare MWH & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MWH | PTGX |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.2B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | MWH | PTGX |
|---|---|---|
| Price | $37.61 | $102.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | $35.42 | ★ $108.23 |
| AVG Volume (30 Days) | ★ 724.3K | 646.5K |
| Earning Date | 03-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.86 | $874.25 |
| Revenue Next Year | $14.78 | N/A |
| P/E Ratio | $50.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.60 | $41.29 |
| 52 Week High | $36.76 | $107.84 |
Technical Indicators
Market Signals| Indicator | MWH | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 74.07 | 52.62 |
| Support Level | $27.32 | $76.63 |
| Resistance Level | N/A | $107.84 |
| Average True Range (ATR) | 1.68 | 3.87 |
| MACD | 0.69 | -0.32 |
| Stochastic Oscillator | 93.22 | 63.32 |
Price Performance
Historical ComparisonAbout MWH SOLV Energy Inc. Class A Common Stock
SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.